<p>猶他醫療產品（NASDAQ:UTMD - 獲取免費報告）於週四發佈了季度財報。根據 Zacks 的報告，該醫療器械供應商本季度每股收益為 0.80 美元。猶他醫療產品的股本回報率為 9.89%，淨利潤率為 30.08%。</p>
<p>獲取 <strong>猶他醫療產品</strong> 的提醒：</p>
<h2>猶他醫療產品股票表現</h2>
<p>週四中午交易時，UTMD 股票上漲 0.02 美元，達到 60.86 美元。該公司的股票交易量為 685 股，而其平均交易量為 13,361 股。該公司的市值為 1.9474 億美元，市盈率為 17.23，貝塔值為 0.33。該公司的 50 日簡單移動平均線為 57.71 美元，200 日簡單移動平均線為 58.80 美元。猶他醫療產品的 52 周低點為 51.26 美元，52 周高點為 64.46 美元。</p>
<h2>猶他醫療產品增加股息</h2>
<p>該公司最近還披露了季度股息，已於 1 月 5 日（星期一）支付。12 月 16 日（星期二）登記在冊的股東獲得了 0.31 美元的股息。這比猶他醫療產品之前的季度股息 0.31 美元有所增加。該股息的除息日期為 12 月 16 日（星期二）。這代表着年化股息為 1.24 美元，股息收益率為 2.0%。猶他醫療產品的股息支付比率為 35.03%。</p>
<h2>分析師設定新目標價</h2>
<p>另外，Weiss Ratings 在 1 月 21 日（星期三）的一份研究報告中重新發布了對猶他醫療產品股票的 “賣出（d+）” 評級。一位投資分析師對該股票給予了賣出評級，根據 MarketBeat.com 的數據，該股票的共識評級為 “賣出”。</p>
<p><strong>查看我們關於猶他醫療產品的最新研究報告</strong></p>
<h2>機構投資者對猶他醫療產品的看法</h2>
<p>一些對沖基金最近增加或減少了對該公司的持股。Comerica Bank 在第三季度將其在猶他醫療產品的持股增加了 435.6%。Comerica Bank 現在擁有 541 股該醫療器械供應商的股票，價值 34,000 美元，此前在該期間又購買了 440 股。BNP Paribas Financial Markets 在第三季度將其在猶他醫療產品的持股增加了 89.6%。BNP Paribas Financial Markets 現在擁有 1,060 股該醫療器械供應商的股票，價值 67,000 美元，此前在上個季度又收購了 501 股。懷俄明州在第二季度購買了猶他醫療產品的新股份，價值 132,000 美元。Advisory Services Network LLC 在第三季度收購了猶他醫療產品的新頭寸，價值 159,000 美元。最後，Russell Investments Group Ltd.在第二季度將其在猶他醫療產品的持股增加了 550.5%。Russell Investments Group Ltd.現在擁有 2,758 股該醫療器械供應商的股票，價值 157,000 美元，此前在上個季度又收購了 2,334 股。目前 69.60% 的股票由機構投資者持有。</p>
<h2>猶他醫療產品公司簡介</h2>
<p>（獲取免費報告）</p>
<p>猶他醫療產品公司（Utah Medical Products, Inc.）NASDAQ: UTMD，總部位於猶他州米德維爾，是一家專注於呼吸治療和病人監測應用的一次性醫療設備的設計、製造和營銷公司。自 1970 年代末成立以來，該公司在氣道管理和用於急性和長期護理環境的非侵入性監測產品方面建立了創新的聲譽。</p>
<p>該公司的核心產品組合包括氣管切開管及相關配件、氣管插管固定器、一次性導管和用於測量呼氣末二氧化碳（CO₂）的傳感器。</p>
<h2>瞭解更多</h2>
<ul>
<li>五隻我們更看好的股票，勝過猶他醫療產品</li>
<li>家族信託如何幫助保護您的財富</li>
<li>請勿刪除，立即閲讀</li>
<li>1933 年退款：特朗普的重置可能創造即時財富</li>
<li>新法律：國會批准數字美元的設立？</li>
<li>用這四個簡單步驟 “防止美聯儲影響” 您的銀行賬户</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VVRNRA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VVRNRA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>您現在應該投資 1,000 美元於猶他醫療產品嗎？</h2>
<p>在您考慮猶他醫療產品之前，您需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而猶他醫療產品並不在名單上。</p>
<p>雖然猶他醫療產品目前在分析師中被評為賣出評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

猶他醫療產品

<p>猶他醫療產品 (NASDAQ:UTMD) 報告了季度每股收益為 $0.80，淨利潤率為 30.08%，股本回報率為 9.89%。該股票交易價格為 $60.86，市值為 $1.9474 億。公司還宣佈季度分紅為 $0.31，維持 2.0% 的收益率。分析師對該股票的共識評級為 “賣出”，近期機構投資顯著增加。猶他醫療產品專注於一次性醫療設備，特別是在呼吸治療和患者監測領域</p>

<p>Utah Medical Products (NASDAQ:UTMD - Get Free Report) posted its quarterly earnings data on Thursday. The medical instruments supplier reported $0.80 earnings per share for the quarter, Zacks reports. Utah Medical Products had a return on equity of 9.89% and a net margin of 30.08%.</p>
<div class="lb-trans"><p>猶他醫療產品（NASDAQ:UTMD - 獲取免費報告）於週四發佈了季度財報。根據 Zacks 的報告，該醫療器械供應商本季度每股收益為 0.80 美元。猶他醫療產品的股本回報率為 9.89%，淨利潤率為 30.08%。</p>
</div><p>Get <strong>Utah Medical Products</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>猶他醫療產品</strong> 的提醒：</p>
</div><h2>Utah Medical Products Stock Performance</h2>
<div class="lb-trans"><h2>猶他醫療產品股票表現</h2>
</div><p>Shares of UTMD stock traded up $0.02 during mid-day trading on Thursday, hitting $60.86. The company's stock had a trading volume of 685 shares, compared to its average volume of 13,361. The company has a market cap of $194.74 million, a PE ratio of 17.23 and a beta of 0.33. The company's fifty day simple moving average is $57.71 and its 200-day simple moving average is $58.80. Utah Medical Products has a 52 week low of $51.26 and a 52 week high of $64.46.</p>
<div class="lb-trans"><p>週四中午交易時，UTMD 股票上漲 0.02 美元，達到 60.86 美元。該公司的股票交易量為 685 股，而其平均交易量為 13,361 股。該公司的市值為 1.9474 億美元，市盈率為 17.23，貝塔值為 0.33。該公司的 50 日簡單移動平均線為 57.71 美元，200 日簡單移動平均線為 58.80 美元。猶他醫療產品的 52 周低點為 51.26 美元，52 周高點為 64.46 美元。</p>
</div><h2>Utah Medical Products Increases Dividend</h2>
<div class="lb-trans"><h2>猶他醫療產品增加股息</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which was paid on Monday, January 5th. Stockholders of record on Tuesday, December 16th were given a $0.31 dividend. This is a boost from Utah Medical Products's previous quarterly dividend of $0.31. The ex-dividend date of this dividend was Tuesday, December 16th. This represents a $1.24 annualized dividend and a dividend yield of 2.0%. Utah Medical Products's dividend payout ratio is 35.03%.</p>
<div class="lb-trans"><p>該公司最近還披露了季度股息，已於 1 月 5 日（星期一）支付。12 月 16 日（星期二）登記在冊的股東獲得了 0.31 美元的股息。這比猶他醫療產品之前的季度股息 0.31 美元有所增加。該股息的除息日期為 12 月 16 日（星期二）。這代表着年化股息為 1.24 美元，股息收益率為 2.0%。猶他醫療產品的股息支付比率為 35.03%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>Separately, Weiss Ratings reissued a &#34;sell (d+)&#34; rating on shares of Utah Medical Products in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of &#34;Sell&#34;.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 1 月 21 日（星期三）的一份研究報告中重新發布了對猶他醫療產品股票的 “賣出（d+）” 評級。一位投資分析師對該股票給予了賣出評級，根據 MarketBeat.com 的數據，該股票的共識評級為 “賣出”。</p>
</div><p><strong>Check Out Our Latest Research Report on Utah Medical Products</strong></p>
<div class="lb-trans"><p><strong>查看我們關於猶他醫療產品的最新研究報告</strong></p>
</div><h2>Institutional Investors Weigh In On Utah Medical Products</h2>
<div class="lb-trans"><h2>機構投資者對猶他醫療產品的看法</h2>
</div><p>A number of hedge funds have recently added to or reduced their stakes in the business. Comerica Bank lifted its stake in Utah Medical Products by 435.6% in the third quarter. Comerica Bank now owns 541 shares of the medical instruments supplier's stock valued at $34,000 after buying an additional 440 shares during the period. BNP Paribas Financial Markets increased its stake in shares of Utah Medical Products by 89.6% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,060 shares of the medical instruments supplier's stock valued at $67,000 after acquiring an additional 501 shares in the last quarter. State of Wyoming bought a new stake in shares of Utah Medical Products in the 2nd quarter valued at $132,000. Advisory Services Network LLC acquired a new position in shares of Utah Medical Products during the 3rd quarter valued at $159,000. Finally, Russell Investments Group Ltd. boosted its stake in Utah Medical Products by 550.5% during the second quarter. Russell Investments Group Ltd. now owns 2,758 shares of the medical instruments supplier's stock worth $157,000 after acquiring an additional 2,334 shares in the last quarter. 69.60% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>一些對沖基金最近增加或減少了對該公司的持股。Comerica Bank 在第三季度將其在猶他醫療產品的持股增加了 435.6%。Comerica Bank 現在擁有 541 股該醫療器械供應商的股票，價值 34,000 美元，此前在該期間又購買了 440 股。BNP Paribas Financial Markets 在第三季度將其在猶他醫療產品的持股增加了 89.6%。BNP Paribas Financial Markets 現在擁有 1,060 股該醫療器械供應商的股票，價值 67,000 美元，此前在上個季度又收購了 501 股。懷俄明州在第二季度購買了猶他醫療產品的新股份，價值 132,000 美元。Advisory Services Network LLC 在第三季度收購了猶他醫療產品的新頭寸，價值 159,000 美元。最後，Russell Investments Group Ltd.在第二季度將其在猶他醫療產品的持股增加了 550.5%。Russell Investments Group Ltd.現在擁有 2,758 股該醫療器械供應商的股票，價值 157,000 美元，此前在上個季度又收購了 2,334 股。目前 69.60% 的股票由機構投資者持有。</p>
</div><h2>Utah Medical Products Company Profile</h2>
<div class="lb-trans"><h2>猶他醫療產品公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Utah Medical Products, Inc NASDAQ: UTMD, headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.</p>
<div class="lb-trans"><p>猶他醫療產品公司（Utah Medical Products, Inc.）NASDAQ: UTMD，總部位於猶他州米德維爾，是一家專注於呼吸治療和病人監測應用的一次性醫療設備的設計、製造和營銷公司。自 1970 年代末成立以來，該公司在氣道管理和用於急性和長期護理環境的非侵入性監測產品方面建立了創新的聲譽。</p>
</div><p>The company's core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).</p>
<div class="lb-trans"><p>該公司的核心產品組合包括氣管切開管及相關配件、氣管插管固定器、一次性導管和用於測量呼氣末二氧化碳（CO₂）的傳感器。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Utah Medical Products</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>Do not delete, read immediately</li>
<li>Refund From 1933: Trump’s Reset May Create Instant Wealth</li>
<li>NEW LAW: Congress Approves Setup For Digital Dollar?</li>
<li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過猶他醫療產品</li>
<li>家族信託如何幫助保護您的財富</li>
<li>請勿刪除，立即閲讀</li>
<li>1933 年退款：特朗普的重置可能創造即時財富</li>
<li>新法律：國會批准數字美元的設立？</li>
<li>用這四個簡單步驟 “防止美聯儲影響” 您的銀行賬户</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VVRNRA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=UTMD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Utah Medical Products Right Now?</h2>
<div class="lb-trans"><h2>您現在應該投資 1,000 美元於猶他醫療產品嗎？</h2>
</div><p>Before you consider Utah Medical Products, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考慮猶他醫療產品之前，您需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而猶他醫療產品並不在名單上。</p>
</div><p>While Utah Medical Products currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然猶他醫療產品目前在分析師中被評為賣出評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

猶他醫療產品（NASDAQ:UTMD）公佈季度財報結果